Innovators Club: Bioconvergence – Unlocking The Potential Of Personalized Medicine

Biography

In her role as Technology Chief of Staff at the Science and Technology Office, Nina Siragusa, PhD is responsible for driving technological advancements by enabling cross-sectoral collaborations within our company. Over the last years, she has held different positions leading and developing early-stage innovation projects at the company´s Innovation Center with a digital core, ultimately driving innovation via global collaboration across Healthcare, Life Science and Electronics business sectors. Nina holds a PhD in biology and advanced her scientific career at the University of Exeter, University of Helsinki, and Yale University.

Biography

Alex Zhavoronkov, PhD, is the founder and CEO of a clinical-stage AI-powered global biotechnology company Insilico Medicine, which raised over $300 million in multiple rounds, nominated 7 preclinical candidates, and entered human clinical trials with an AI-discovered and AI-designed antifibrotic. He is also an adjunct professor of artificial intelligence at the Buck Institute for Research on Aging. Since 2014 he published over 150 peer-reviewed academic publications and two books.

Biography

Ravi Kiron, PhD, based in California, USA, is an experienced pharma/biotech executive with decades of experience in Discovery R&D through late-stage clinical development, intellectual property and regulatory, technology & business development, M&A, strategy, and product commercialization. Currently, he is exploring cutting edge game-changing technologies and establishing strategic partnerships to have an impact on pharma/biotech product development. Dr. Kiron holds a BS in Chemistry, MS in Microbiology from the University of Mumbai, India, a PhD in Biochemistry from the Indian Institute of Science, India, and an MBA from Rensselaer Polytechnic Institute, New York, USA.